A 2023 study also revealed that the use of GLP-1 agonists for weight loss is linked to an increased risk of developing the following conditions: The incidence of acute pancreatitis and pancreatic cancer was studied in 56,000 type 2 diabetes mellitus patients on GLP-1 medication for 1 to 5 years
Wang XH, Li L, Holscher C, Pan YF, Chen XR, Qi JS
The receipt took a long time to load and initially showed an error
If nothing happens, walk away and try again after breakfast
Do not exceed the manufacturer's recommended dosage
GLP-1 Considerations For Health Plans Financial Implications Like any other drug being added to CMS Formulary Reference File, health plans must consider the holistic impact of adding or not adding Wegovy to formularies